» książki » Business & Economics - Industries - Pharmaceutical & Biotechnology
topmenu
Kategoria BISAC: Business & Economics >> Industries - Pharmaceutical & Biotechnology
ilość książek w kategorii: 586
 |
Drugs to Market: Creating Value and Advantage in the Pharmaceutical Industry
ISBN: 9780080425597 / Angielski / Twarda / 208 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Hardbound. The development and marketing of drugs since the Second World War offers an exemplary demonstration of the impact of technology on competitiveness in a major industry. While focusing primarily on the market in the USA, this study examines also the activities of European firms, their contribution to the industry's technological evolution and the impact of their entry into the US market.The main concern of the book, however, is to examine all the elements which go to make up the evolving landscape of competition, and their interaction. Thus, the effects of technological change are...
Hardbound. The development and marketing of drugs since the Second World War offers an exemplary demonstration of the impact of technology on competit...
|
cena:
398,53 zł |
 |
The Truth About the Drug Companies: How They Deceive Us and What to Do About It
ISBN: 9780375760945 / Angielski / Miękka / 352 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet...
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the ...
|
cena:
76,32 zł |
 |
The Moral Corporation
ISBN: 9780521683838 / Angielski / Miękka / 196 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a...
Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop th...
|
cena:
148,75 zł |
 |
The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers
ISBN: 9781586481858 / Angielski / Miękka / 208 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. As the pharmaceutical industry invests more and more in the development of new drugs, true breakthroughs are few and far between. Into the breach comes a panoply of product-line extensions and me-too drugs aimed at grabbing market share. The industry plows its high profits back into research, but invests an equal or greater sum in flogging its products in every imaginable venue. Research studies are designed to support marketing claims. Many doctors all over the country get their first information about new drugs from a salesperson. And, increasingly, prescription drugs are pitched to...
As the pharmaceutical industry invests more and more in the development of new drugs, true breakthroughs are few and far between. Into the breach come...
|
cena:
108,43 zł |
 |
Research & Development in the Pharmaceutical Industry
ISBN: 9781606929711 / Angielski / Twarda / 135 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Reviews basic facts about the drug industry's spending on research and development (R and D) and its output of drugs. This title examines issues relating to the costs of R and D, the federal government's role in pharmaceutical research, and the performance of the pharmaceutical industry in developing innovative drugs.
Reviews basic facts about the drug industry's spending on research and development (R and D) and its output of drugs. This title examines issues relat...
|
cena:
440,84 zł |
 |
Regulated Bioanalytical Laboratories: Technical and Regulatory Aspects from Global Perspectives
ISBN: 9780470476598 / Angielski / Twarda / 548 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Developing and implementing strategies for routine, non-routine, and standard bioanalytical methods and on the entire equipment hardware and software qualification process, is the topic of this book. It includes guidelines on qualification of certified standards and in-house reference material as well as on people qualification.
Developing and implementing strategies for routine, non-routine, and standard bioanalytical methods and on the entire equipment hardware and software ...
|
cena:
725,91 zł |
 |
Outsourcing Biopharma R&d to India
ISBN: 9781907568084 / Angielski / Twarda / 130 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology companies have made India their choice for a research destination. Initially R&D was inclined more towards developing products for the Indian market within the country. This led to several multinational companies opening up production plants in India, primarily due to the globalization of the Indian economy and offshoring jobs to India. Alongside, several global pharma-biotech majors ascertained large market requirements within the country and...
The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology c...
|
cena:
682,50 zł |
 |
Market Menagerie: Health and Development in Late Industrial States
ISBN: 9780804780544 / Angielski / Twarda / 344 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Market Menagerie addresses the tensions between economic and social policies. This book explores how states, markets, and other institutions interact within the health industry-using India as a primary case study.
Market Menagerie addresses the tensions between economic and social policies. This book explores how states, markets, and other institutions interact ...
|
cena:
342,34 zł |
 |
The Economics of Us Health Care Policy
ISBN: 9780415784320 / Angielski / Miękka / 236 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. |
cena:
259,30 zł |
 |
The Economics of Us Health Care Policy
ISBN: 9780415784313 / Angielski / Twarda / 236 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. |
cena:
803,99 zł |
 |
The Life Science Innovation Roadmap: Bioscience Innovation Assessment, Planning, Strategy, Execution, and Implementation
ISBN: 9781934899274 / Angielski / Miękka / 228 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. This book is intended for scientists, engineers, physicians, business people, and service providers at all levels who are interested in and support the process of life science commercialization. ¬ The authors provide a hands-on template for success based on their years of experience practicing and teaching bioentrepreneurship and consulting to clients, students, economic development agencies, and faculty around the world.
This book is intended for scientists, engineers, physicians, business people, and service providers at all levels who are interested in and support th...
|
cena:
307,35 zł |
 |
Pharmaceutical Process Design and Management
ISBN: 9781409427117 / Angielski / Twarda / 288 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. A quality product or service is the successful and profitable outcome of organising resources, as judged by the final customer. Every business unit needs processes in order to do this effectively; and all processes must be documented so that achievements can be measured and future improvements planned and implemented. Pharmaceutical Process Design and Management takes a step-wise approach to process management. It presents the various elements comprising a process (man, machine, materials, method and environment); it looks at quality control and quality assurance, tools for quality...
A quality product or service is the successful and profitable outcome of organising resources, as judged by the final customer. Every business unit ne...
|
cena:
700,25 zł |
 |
The Life Science Innovation Roadmap: Bioscience Innovation Assessment, Planning, Strategy, Execution, and Implementation
ISBN: 9781934899267 / Angielski / Twarda / 228 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. This book is intended for scientists, engineers, physicians, business people, and service providers at all levels who are interested in and support the process of life science commercialization. - The authors provide a hands-on template for success based on their years of experience practicing and teaching bioentrepreneurship and consulting to clients, students, economic development agencies, and faculty around the world."
This book is intended for scientists, engineers, physicians, business people, and service providers at all levels who are interested in and support th...
|
cena:
397,75 zł |
 |
Switch Dynamics - A Practical Approach to Switching Medicines for Self Care
ISBN: 9780957537200 / Angielski / Miękka / 160 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. A practical guide for those in pharmaceutical companies considering a reclassification (switch) project including Rx to OTC, POM to P, and P to GSL.
The book covers past UK switches with key learning and a framework for initiating, setting up and running switch projects within companies. Plus case studies, insight and practical experience to help companies manage and implement successful switch projects. A practical guide for those in pharmaceutical companies considering a reclassification (switch) project including Rx to OTC, POM to P, and P to GSL. |
cena:
384,79 zł |
 |
Transforming Big Pharma: Assessing the Strategic Alternatives
ISBN: 9781409448273 / Angielski / Twarda / 284 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the...
In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new product...
|
cena:
700,25 zł |
 |
Pharmageddon
ISBN: 9780520270985 / Angielski / Twarda / 320 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of...
This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in hea...
|
cena:
191,10 zł |
 |
Pharmageddon
ISBN: 9780520275768 / Angielski / Miękka / 320 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of...
This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in hea...
|
cena:
136,50 zł |
 |
Building Biotechnology: Biotechnology Business, Regulations, Patents, Law, Policy and Science
ISBN: 9781934899298 / Angielski / Miękka / 388 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope.
In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first... Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book descri...
|
cena:
322,67 zł |
 |
Building Biotechnology: Biotechnology Business, Regulations, Patents, Law, Policy and Science
ISBN: 9781934899281 / Angielski / Twarda / 388 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first...
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book descri...
|
cena:
365,72 zł |
 |
Bioscience, Governance and Politics
ISBN: 9781137374981 / Angielski / Twarda / 203 str. Termin realizacji zamówienia: ok. 5-8 dni roboczych. Through case studies, theoretical research and interviews with leading players in science and governance, this book introduces a new understanding of change in governance of bioscience research. In particular it examines change as it is shaped by approaches developed by Science and Technology Studies and Sociology of Scientific Knowledge theorists.
Through case studies, theoretical research and interviews with leading players in science and governance, this book introduces a new understanding of ...
|
cena:
192,30 zł |
Czytaj nas na:
Zobacz: Księgarnia Czeska | Wydawnictwo Książkowe Klimaty | Mapa strony | Lista autorów
KrainaKsiazek.PL - Księgarnia Internetowa
KrainaKsiazek.PL - Księgarnia Internetowa
